E-cigarettes with a mint flavor are more likely to deteriorate lung health.

Published Date: 24 Apr 2023

Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.

Read Full News

Latest News

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

My Job Has Become Mounds of Paperwork. Work Requirements Will Make it Worse.

The new Medicaid rule is unworkable

FDA Says Juul Can Sell Updated Vaping Device With Age-Gating Technology

Agency allows company to sell a new version of its top-selling device

FDA Approves Four Updated COVID Shots Targeting XFG Variant

Approvals come as the CDC's vaccine advisory panel remains in legal limbo

Doctors Groups Offer Updated Flu, COVID Vaccine Recs to Ease Confusion

AMA, AAFP, IDSA, and others are issuing the guidelines and highlighting the science behind them

Docs Alarmed by NIH Plan to Redirect Medical Research $$ to Pentagon

Few details are available on the proposal, which has a 5-day comment period

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Latest News

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

The new Medicaid rule is unworkable

Agency allows company to sell a new version of its top-selling device

Approvals come as the CDC's vaccine advisory panel remains in legal limbo

AMA, AAFP, IDSA, and others are issuing the guidelines and highlighting the science behind them

Few details are available on the proposal, which has a 5-day comment period

News All Time

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Holistic Care Must Be Standard in Lung Disease

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

CPAP May Offer Enhanced BP Benefit in Sleep Apnea & Insomnia

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Wildfires Expose Millions in the Midwest and Northeast U.S. to Dangerous Smoke

States warned residents about air quality issues that could last for days

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

Wildfire Smoke Kills Tens of Thousands Each Year. Here's How It Attacks the Body.

"It's a big giant toxic soup of particles and gases," expert says

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

CDC Suggests Threat of Mold-Associated Illnesses May Be Underappreciated

"It's kind of the first time we've had an estimate like this," the study's senior author says

Recommended News For You

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

Novel Agent Effective for Cancer Wasting Disorder

Abemaciclib Slows Progression of Advanced Liposarcoma

BMI is linked to heart damage from chemotherapy in breast cancer patients.

The top three drugs for multiple myeloma treatment upfront are four.

Alkem introduces cetuximab under the trade name Cetuxa in India.

Recommended Articles For You

A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures 

What Is Carboxyhemoglobin And How Can It Affect Your Health? 

Quality of Life Through Functional Reintegration After Organ-Conserving Cancer Care 

Target-Mediated Drug Disposition in Hematologic Therapeutics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study suggests exercise could reduce breast cancer recurrence

2.

Prostate cancer early detection system eliminates need for biopsy.

3.

Breast cancer-related fatigue: The benefits of adapted physical activity

4.

TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share

5.

Which Risk Model Better Identifies High-Risk Smoldering MM?

1.

Drug Safety Surveillance for Emerging Immuno-Oncology Medication Risks

2.

The Science Behind Imatinib: How It Targets Cancer Cells 

3.

Seeing Beyond the Pink Ribbon: AI's New Battle Against Breast Cancer

4.

A Revolutionary Guide to Calculating Absolute Neutrophil Counts

5.

Contemporary Advances in Hematology in the Digital Era

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

3.

How Advances in Cancer Research Are Improving Treatment Options

4.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

5.

Nutrition During Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot